Previous Investigations
Other Litigations heparin Heparin contamination
|
Oversulfated Condroitin Sulfate Identified as Contaminant in Blood-Thinner Heparin
On March 19, 2008, the New York Times reported that the contaminant in batches of the blood thinner heparin associated with 19 deaths has been identified as Oversulfated Condroitin Sulfate.
Currently, health officials are trying to determine how the chemical got into the drug. According to the New York Times, while condroitin sulfate is a natural compound that occurs widely and is used as a dietary supplement, the oversulfated version has not been widely studied.
According to Dr. Janet Woodcock, head of the FDA's Center for Drug Evaluation and Research, it has not yet been determined whether the contaminant was introduced accidentally or intentionally. Additionally, the FDA has initiated testing of imported heparin entering this country and Woodcock said that the FDA feels that consumers can now be confident that the product on the market has been tested and is safe.
If you were harmed from heparin contamination, please complete the form below and a representative of our firm will contact you as soon as possible. We hope to assist you in the legal aspects involved with heparin contamination
see also:
Heparin and Celsus
NY heparin lawyers: Heparin seized from Celsus Laboratories in OhioFree case review; information on heparin and Celsus Laboratories
Adverse reactions
New York Heparin Lawyers: Adverse reaction from Heparin? Click hereFree case review from Heparin lawyers for those with adverse reactions
Heparin contamination
Information on Heparin contaminationGet FREE lawsuit review about Heparin contamination
